News
Tiedote osakkeenomistajille / Notice to shareholders
TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »
News release on April 12, 2024
The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »
Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen
Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »
New distributor agreement with “GENFAX SRL”
We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »
Season greetings!
Injeq kiittää kaikkia asiakkaitaan ja sidosryhmiään yhteistyöstä vuonna 2023 ja toivottaa rauhallista joulun aikaa! Onnea ja iloa uuteen vuoteen 2024! […]
Read more »
New distributor in the Kingdom of Saudi Arabia
Injeq is happy to announce its recent distribution agreement with Techno Orbits, a premier technology healthcare solution company in the […]
Read more »
Research news: A previous champagne tap reduces the probability of traumatic lumbar puncture in the following procedure
Injeq’s Harri Sievänen has publish new interesting findings about the incidence of traumatic lumbar punctures. “According to binary logistic regression, […]
Read more »
Breakthrough Device designation granted by FDA
Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »
Large multicenter trial of pediatric hemato-oncology patients sponsored by Injeq
A clinical investigation conducted in all five Finnish university hospitals and sponsored by Injeq has begun in May. A peer-reviewed […]
Read more »
Tiedote
Injeq on yhdessä Invesdorin kanssa järjestellyt osakeantia, joka käynnistyy ns. ”hiljaisella kierroksella”, jolloin nykyiset omistajat pääsevät merkitsemään osakkeita ensin, jonka […]
Read more »